Wealthfront Advisers
CC icon

Wealthfront Advisers’s Chemours CC Stock Holding History

Wealthfront Advisers’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,567
Closed -$938K – 1120
2026
Q1 		$938K Sell
42,567
-4,733
-10% -$82.4K ﹤0.01% 727
2025
Q4 		$558K Sell
47,300
-129
-0.3% -$1.66K ﹤0.01% 802
2025
Q3 		$751K Buy
47,429
+161
+0.3% +$2.33K ﹤0.01% 749
2025
Q2 		$541K Sell
47,268
-1,488
-3% -$16.8K ﹤0.01% 778
2025
Q1 		$660K Buy
48,756
+15,813
+48% +$263K ﹤0.01% 732
2024
Q4 		$557K Buy
32,943
+17,285
+110% +$336K ﹤0.01% 763
2024
Q3 		$318K Buy
+15,658
New +$320K ﹤0.01% 825

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HPC
Highland Peak Capital Old Greenwich, Connecticut $344M AUM 141.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wealthfront Advisers's CC Position: Q2 2026 in Review

Wealthfront Advisers sold out of Chemours (CC) in Q2 2026, closing a stake of 42,567 shares — an estimated $938K sold.

Wealthfront Advisers first reported a position in CC in Q3 2024 and held it in 7 quarters. The position peaked at $938K in Q1 2026. 313 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Wealthfront Advisers reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
  • Wealthfront Advisers sold 42,567 Chemours shares in Q2 2026, an estimated $938K.
  • Wealthfront Advisers first reported a position in Chemours in Q3 2024 and held it in 7 quarters.
  • Wealthfront Advisers's Chemours position peaked at $938K in Q1 2026.
  • 313 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.